Prostate Cancer Reports


Volume 1 Supplement 1
 January 2013

Home > Prostate Cancer Reports > Volume 1 - Year 2013 > Supplement 1, January 2013

CONTENTS



Clinical & Lab investigations
Localized PCa
Low-risk PCa



CLINICAL & LAB INVESTIGATIONS


Familiality

Hemminki K, Sundquist J, Brandt A.
Familial mortality and familial incidence in cancer.
J Clin Oncol. 2011 Feb 20;29(6):712-8. doi: 10.1200/JCO.2010.30.5664. Epub 2011 Jan 4.
Abstract | Full text | Related citations


Finasteride

Vickers AJ, Savage CJ, Lilja H.
Finasteride to prevent prostate cancer: should all men or only a high-risk subgroup be treated?
J Clin Oncol. 2010 Mar 1;28(7):1112-6. doi: 10.1200/JCO.2009.23.5572. Epub 2010 Feb 1.
Abstract | Full text | Related citations


Gleason score

Porten SP, Whitson JM, Cowan JE, Cooperberg MR, Shinohara K, Perez N, Greene KL, Meng MV, Carroll PR.
Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance.
J Clin Oncol. 2011 Jul 10;29(20):2795-800. doi: 10.1200/JCO.2010.33.0134. Epub 2011 May 31.
Abstract | Full text | Related citations


Mortality

Penney KL, Sinnott JA, Fall K, Pawitan Y, Hoshida Y, Kraft P, Stark JR, Fiorentino M, Perner S, Finn S, Calza S, Flavin R, Freedman ML, Setlur S, Sesso HD, Andersson SO, Martin N, Kantoff PW, Johansson JE, Adami HO, Rubin MA, Loda M, Golub TR, Andrén O, Stampfer MJ, Mucci LA.
mRNA expression signature of Gleason grade predicts lethal prostate cancer.
J Clin Oncol. 2011 Jun 10;29(17):2391-6. doi: 10.1200/JCO.2010.32.6421. Epub 2011 May 2.
Abstract | Full text | Related citations


Nutrition

Chan JM, Oh WK, Xie W, Regan MM, Stampfer MJ, King IB, Abe M, Kantoff PW.
Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer.
J Clin Oncol. 2009 Aug 1;27(22):3577-83. doi: 10.1200/JCO.2008.18.8938. Epub 2009 Jun 15.
Abstract | Full text | Related citations


Meyerhardt JA, Ma J, Courneya KS.
Energetics in colorectal and prostate cancer.
J Clin Oncol. 2010 Sep 10;28(26):4066-73. doi: 10.1200/JCO.2009.26.8797. Epub 2010 Jul 19.
Abstract | Full text | Related citations


Nguyen PL, Ma J, Chavarro JE, Freedman ML, Lis R, Fedele G, Fiore C, Qiu W, Fiorentino M, Finn S, Penney KL, Eisenstein A, Schumacher FR, Mucci LA, Stampfer MJ, Giovannucci E, Loda M.
Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival.
J Clin Oncol. 2010 Sep 1;28(25):3958-64. doi: 10.1200/JCO.2009.27.0793. Epub 2010 Aug 2.
Abstract | Full text | Related citations


Platz EA, Lippman SM.
Selenium, genetic variation, and prostate cancer risk: epidemiology reflects back on selenium and vitamin E cancer prevention trial.
J Clin Oncol. 2009 Aug 1;27(22):3569-72. doi: 10.1200/JCO.2009.22.2117. Epub 2009 Jun 15. No abstract available. Erratum in: J Clin Oncol. 2010 Dec 1;28(34):5126. Lippman, Scott M [added].
Abstract | Full text | Erratum | Related citations


Physical activity

Kenfield SA, Stampfer MJ, Giovannucci E, Chan JM.
Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study.
J Clin Oncol. 2011 Feb 20;29(6):726-32. doi: 10.1200/JCO.2010.31.5226. Epub 2011 Jan 4.
Abstract | Full text | Related citations


Wei EK, Wolin KY, Colditz GA.
Time course of risk factors in cancer etiology and progression.
J Clin Oncol. 2010 Sep 10;28(26):4052-7. doi: 10.1200/JCO.2009.26.9324. Epub 2010 Jul 19.
Abstract | Related citations


Prostate-specific antigen

Carroll PR, Whitson JM, Cooperberg MR.
Serum prostate-specific antigen for the early detection of prostate cancer: always, never, or only sometimes?
J Clin Oncol. 2011 Feb 1;29(4):345-7. doi: 10.1200/JCO.2010.32.5308. Epub 2010 Dec 28.
Abstract | Full text | Related citations



Crawford ED, Grubb R 3rd, Black A, Andriole GL Jr, Chen MH, Izmirlian G, Berg CD, D'Amico AV.
Comorbidity and mortality results from a randomized prostate cancer screening trial.
J Clin Oncol. 2011 Feb 1;29(4):355-61. doi: 10.1200/JCO.2010.30.5979. Epub 2010 Nov 1.
Abstract | Full text | Italian Full text | Related citations


Risk stratification

Gann PH, Fought A, Deaton R, Catalona WJ, Vonesh E.
Risk factors for prostate cancer detection after a negative biopsy: a novel multivariable longitudinal approach.
J Clin Oncol. 2010 Apr 1;28(10):1714-20. doi: 10.1200/JCO.2008.20.3422. Epub 2010 Feb 22.
Abstract | Full text | Related citations


Statins

Gutt R, Tonlaar N, Kunnavakkam R, Karrison T, Weichselbaum RR, Liauw SL.
Statin use and risk of prostate cancer recurrence in men treated with radiation therapy.
J Clin Oncol. 2010 Jun 1;28(16):2653-9. doi: 10.1200/JCO.2009.27.3003. Epub 2010 Apr 26.
Abstract | Full text | Related citations


Survival

Bechis SK, Carroll PR, Cooperberg MR.
Impact of age at diagnosis on prostate cancer treatment and survival.
J Clin Oncol. 2011 Jan 10;29(2):235-41. doi: 10.1200/JCO.2010.30.2075. Epub 2010 Dec 6.
Abstract | Full text | Related citations

LOCALIZED PROSTATE CANCER


Comorbidity


Albertsen PC, Moore DF, Shih W, Lin Y, Li H, Lu-Yao GL.
Impact of comorbidity on survival among men with localized prostate cancer.
J Clin Oncol. 2011 Apr 1;29(10):1335-41. doi: 10.1200/JCO.2010.31.2330. Epub 2011 Feb 28.
Abstract | Full text | Related citations


Primary treatment



Cooperberg MR, Broering JM, Carroll PR.
Time trends and local variation in primary treatment of localized prostate cancer.
J Clin Oncol. 2010 Mar 1;28(7):1117-23. doi: 10.1200/JCO.2009.26.0133. Epub 2010 Feb 1.
Abstract | Full text | Related citations

LOW-RISK PROSTATE CANCER


Active surveillance



Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A.
Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer.
J Clin Oncol. 2010 Jan 1;28(1):126-31. doi: 10.1200/JCO.2009.24.2180. Epub 2009 Nov 16.
Abstract | Full text | Related citations


Ross AE, Loeb S, Landis P, Partin AW, Epstein JI, Kettermann A, Feng Z, Carter HB, Walsh PC.
Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program.
J Clin Oncol. 2010 Jun 10;28(17):2810-6. doi: 10.1200/JCO.2009.25.7311. Epub 2010 May 3.
Abstract | Full text | Related citations


Whitson JM, Carroll PR.
Active surveillance for early-stage prostate cancer: defining the triggers for intervention.
J Clin Oncol. 2010 Jun 10;28(17):2807-9. doi: 10.1200/JCO.2010.28.5817. Epub 2010 May 3
Abstract | Full text | Related citations